Detroit MI 小细胞肺癌临床试验
12项针对 小细胞肺癌的研究正在 Detroit及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
招募中2 期
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
招募中1/2 期
- Barbara Ann Karmanos Cancer Center, Detroit
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
招募中3 期
- Henry Ford Health Cancer, Detroit
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中1/2 期
- Karmanos Cancer Institute, Detroit
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
招募中1 期
- Henry Ford Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- Karmanos Cancer Institute, Detroit
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
招募中3 期
- Henry Ford Health System, Detroit
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
招募中2 期
- Henry Ford Cancer- Detroit, Detroit
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
招募中2 期
- Karmanos Cancer Center (Wayne State University), Detroit
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
招募中2 期
- Henry Ford Health Saint John Hospital, Detroit
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
招募中1/2 期
- Henry Ford Health System, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 129, Detroit
其他城市的 小细胞肺癌试验
- Houston, TX26 项研究
- Arlington, VA23 项研究
- New York City, NY22 项研究
- Boston, MA21 项研究
- Los Angeles, CA20 项研究
- Nashville, TN20 项研究
- Orlando, FL15 项研究
- Chicago, IL13 项研究
- St. Louis, MO13 项研究
- Dallas, TX13 项研究
- Cleveland, OH13 项研究
- Washington, DC12 项研究
Detroit的其他研究
- 非小细胞肺癌44 项研究
- 乳腺癌34 项研究
- 癌症(所有类型)29 项研究
- 结直肠癌26 项研究
- 卵巢癌26 项研究
- 转移性癌症24 项研究
- 前列腺癌22 项研究
- 子宫内膜癌21 项研究
- 肺癌20 项研究
- 多发性骨髓瘤19 项研究
- 胃癌16 项研究
- 头颈鳞状细胞癌15 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月7日。每项研究自行设定入选标准,由研究团队决定谁能参与。